AI Article Synopsis

  • The study aimed to assess the time in therapeutic range (TTR) of international normalized ratio (INR) in patients treated with warfarin, focusing on various factors influencing TTR.
  • The results showed that the average TTR was low (55.92%), with only 48% of patients achieving efficient TTR, and TTR correlated with the frequency of INR visits per year.
  • Patient awareness of their target INR was low (30.2%), with literacy and duration of warfarin use positively influencing this awareness, indicating the need for improved education and monitoring.

Article Abstract

Objective: The time in therapeutic range (TTR) of international normalized ratio (INR) is essential for the safety and efficacy of warfarin treatment. In this study, we aimed to determine TTR and the factors that affect TTR in patients using warfarin.

Methods: Patients taking warfarin for valvular and nonvalvular atrial fibrillation (AF) or prosthetic heart valves who were admitted to our cardiology outpatient clinic were enrolled. TTR was calculated using the linear interpolation method. The patients were analyzed according to warfarin indications and TTR efficiency (TTR ≥60%). Weekly warfarin dose, the duration of warfarin use, the frequency of INR visits per year, and the awareness of patients regarding target INR were noted.

Results: The TTR of 248 patients (aged 57.21±12.45 years, 33.1% male) was 55.92±27.84%, and 48.0% patients exhibited efficient TTR. Clinical and demographic characteristics (age, sex, socioeconomic status, and comorbidities) exerted no effect on TTR and TTR efficiency. The frequency of INR visits per year was 10.02±3.80. TTR was related to the frequency of annual INR visits (r=0.131, p=0.039). Only one-third (30.2%) of patients were aware of their target INR. The literacy of the patients and duration of warfarin use exerted a positive effect on awareness (p=0.011 and p=0.024, respectively).

Conclusion: The findings of our study demonstrated that TTR and TTR efficiency were low and not associated with the characteristics of patients or indications. Unfortunately, in patients with valvular AF and prosthetic valves, warfarin is the sole drug that can be used. Thus, awareness and knowledge regarding target INR are essential to overcome poor anticoagulation monitoring with frequent INR visits.

Download full-text PDF

Source
http://dx.doi.org/10.5543/tkda.2021.21015DOI Listing

Publication Analysis

Top Keywords

inr visits
16
ttr
13
time therapeutic
12
therapeutic range
12
ttr efficiency
12
target inr
12
patients
11
warfarin
8
patients warfarin
8
inr
8

Similar Publications

Medication therapy problems detected at community pharmacy INR checks.

Can Pharm J (Ott)

December 2024

Pharmacy Association of Nova Scotia, Halifax, Nova Scotia.

Background: Despite the shift towards direct-acting anticoagulants, warfarin remains widely used in Canada and is traditionally managed by family physicians through laboratory-based international normalized ratio (INR) testing. The Community Pharmacy Anticoagulation Management Service (CPAMS) in Nova Scotia represents an innovative approach, enabling community pharmacists to conduct point-of-care (POC) INR testing and manage warfarin therapy. A potential benefit of this approach is the opportunity to identify non-warfarin medication therapy problems (nwMTPs) during routine visits.

View Article and Find Full Text PDF

Aim: Indocyanine green (ICG) clearance, a sensitive biomarker for liver function, has not been validated in children. We assessed the association between ICG clearance and liver function in children with liver disease.

Methods: ICG plasma disappearance rate (ICG-PDR, %/min) was measured in children with liver disease.

View Article and Find Full Text PDF

Background: An accurate estimate of the survival and mortality at the initial trauma evaluation is essential to ensure appropriate triage and stratification of the patients for progressive care. One of the recognized tools for predicting mortality is the BIG Score, composed of admission base deficit, international normalized ratio (INR), and Glasgow Coma Scale (GCS). This study evaluates the BIG scale in predicting survival and mortality rates among pediatric trauma patients.

View Article and Find Full Text PDF

The purpose of this case report is to describe a case of switching warfarin to apixaban in a patient on anticoagulant prophylaxis for a patent foramen ovale (PFO)-associated stroke. An 86-year-old Afro-Latina female with a past medical history of cerebrovascular accident (CVA) in 2012 secondary to PFO and diagnosed Atrial Fibrillation (AF). Patient was switched from warfarin to apixaban after 3 months of labile international normalized ratio (INR) levels.

View Article and Find Full Text PDF

Background: The closure of a pharmacy-led anticoagulation clinic, which provided point-of-care (POC) international normalized ratio (INR) testing and face-to-face visits, coupled with the transition to an academic physician-led clinic without POC INR testing and reliance on telephone communication, created significant challenges for warfarin management during the Coronavirus disease 2019 pandemic. The aim of this quality control project was to increase the percentage of patients on warfarin within the optimal time in therapeutic range (TTR) from 52.30% to 65.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!